Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

UPDATE — 2/11/26, 12 p.m. ET: Alyssa Farah Griffin is officially a mom after giving birth to her first baby with husband Justin Griffin. “The first thing we want to do is start by congratulating ...

The Sarasota County Sheriff's Office is investigating a shooting at 4822 Fallcrest Cir. in Sarasota. FAA dramatically ends airspace closure after hours of chaos Donald Trump reacts to "great" jobs ...

The Federal Communications Commission (FCC) launched a probe into ABC’s “The View” after the program held an interview with Democratic Texas Senate candidate James Talarico, according to multiple ...

Tesla CEO Elon Musk said Wednesday that the company would begin phasing out its Model S and Model X electric vehicles this year and retool a California factory to produce humanoid robots instead. The ...

On Tesla's fourth-quarter earnings call, CEO Elon Musk said the company is ending production of its Model S and X vehicles. "It's time to basically bring the Model S and X programs to an end with an ...

The show must go on! Though New York and several other states are in the midst of cleaning up a massive snowstorm, The View still recorded a new episode on Monday, January 26. However, the NYC-based ...

On social media, even the weather isn’t safe from artificial intelligence slop. When Hurricane Melissa devastated Jamaica this summer, for example, phony AI-generated videos fooled some people into ...

Key abstracts on multiple myeloma from the 2025 American Society of Hematology Annual Meeting are reported by Dr Joseph Mikhael, chief medical officer of the International Myeloma Foundation. Dr ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

Lipoic acid (LA), an oral antioxidant supplement, was not associated with greater improvements in timed walking speed or other clinical outcomes in patients with progressive multiple sclerosis (MS) ...